RhumbLine Advisers’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $575K | Buy |
112,273
+45,467
| +68% | +$233K | ﹤0.01% | 2598 |
|
|
2025
Q1 | $91.5K | Buy |
66,806
+1,066
| +2% | +$1.46K | ﹤0.01% | 3416 |
|
|
2024
Q4 | $203K | Buy |
65,740
+1,895
| +3% | +$5.86K | ﹤0.01% | 3193 |
|
|
2024
Q3 | $492K | Sell |
63,845
-3,495
| -5% | -$26.9K | ﹤0.01% | 2705 |
|
|
2024
Q2 | $578K | Sell |
67,340
-4,097
| -6% | -$35.2K | ﹤0.01% | 2566 |
|
|
2024
Q1 | $567K | Buy |
71,437
+1,047
| +1% | +$8.31K | ﹤0.01% | 2588 |
|
|
2023
Q4 | $697K | Buy |
70,390
+624
| +0.9% | +$6.18K | ﹤0.01% | 2480 |
|
|
2023
Q3 | $786K | Sell |
69,766
-859
| -1% | -$9.67K | ﹤0.01% | 2345 |
|
|
2023
Q2 | $234K | Sell |
70,625
-1,096
| -2% | -$3.64K | ﹤0.01% | 3156 |
|
|
2023
Q1 | $283K | Buy |
71,721
+1,031
| +1% | +$4.07K | ﹤0.01% | 2633 |
|
|
2022
Q4 | $513K | Buy |
70,690
+938
| +1% | +$6.81K | ﹤0.01% | 2450 |
|
|
2022
Q3 | $253K | Buy |
69,752
+3,818
| +6% | +$13.8K | ﹤0.01% | 2807 |
|
|
2022
Q2 | $299K | Buy |
+65,934
| New | +$299K | ﹤0.01% | 2753 |
|